Cardinal Capital Management Inc. Has $29.55 Million Holdings in Nutrien Ltd. (NYSE:NTR)

Cardinal Capital Management Inc. raised its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 9.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 595,187 shares of the company's stock after acquiring an additional 50,545 shares during the period. Cardinal Capital Management Inc. owned approximately 0.12% of Nutrien worth $29,552,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in NTR. Norges Bank bought a new stake in Nutrien during the 4th quarter valued at approximately $241,958,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Nutrien by 159.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock worth $242,976,000 after buying an additional 3,341,169 shares during the last quarter. Barclays PLC boosted its position in shares of Nutrien by 192.7% in the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock valued at $18,395,000 after acquiring an additional 854,543 shares during the period. Deutsche Bank AG boosted its position in shares of Nutrien by 11.3% in the fourth quarter. Deutsche Bank AG now owns 7,105,057 shares of the company's stock valued at $317,951,000 after acquiring an additional 721,935 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Nutrien by 30.3% in the fourth quarter. Geode Capital Management LLC now owns 3,022,551 shares of the company's stock worth $137,202,000 after acquiring an additional 702,948 shares during the last quarter. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Price Performance

Shares of NYSE NTR traded up $0.34 during midday trading on Wednesday, reaching $60.18. 2,059,640 shares of the company traded hands, compared to its average volume of 2,164,747. Nutrien Ltd. has a 12 month low of $43.70 and a 12 month high of $60.92. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock's 50-day simple moving average is $55.52 and its 200-day simple moving average is $51.69. The firm has a market cap of $29.35 billion, a PE ratio of 43.93, a PEG ratio of 1.19 and a beta of 0.81.

Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.24). The firm had revenue of $4.67 billion for the quarter, compared to the consensus estimate of $5.16 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company's revenue for the quarter was down 5.4% on a year-over-year basis. During the same period in the prior year, the business earned $0.46 earnings per share. As a group, equities analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current fiscal year.

Nutrien Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 18th. Investors of record on Monday, June 30th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.18 dividend on an annualized basis and a yield of 3.62%. Nutrien's dividend payout ratio (DPR) is presently 203.74%.

Wall Street Analyst Weigh In

Several research firms recently commented on NTR. Berenberg Bank upped their target price on shares of Nutrien from $54.00 to $59.00 and gave the company a "buy" rating in a research note on Tuesday, April 15th. BNP Paribas raised shares of Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Wells Fargo & Company increased their target price on shares of Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a research note on Monday, May 12th. CIBC boosted their price target on Nutrien from $64.00 to $66.00 and gave the company an "outperformer" rating in a research note on Tuesday, February 25th. Finally, Bank of America upped their price target on Nutrien from $60.00 to $63.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $61.44.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.